Comment: Worsening Heart Failure in the Setting of Dronedarone Initiation

Coons JC , Plauger KM , Seybert AL , Sokos GG . Worsening heart failure in the setting of dronedarone initiation. Ann Pharmacother 2010; 44:1496–500. DOI 10.1345/aph.1P075

K⊘ber L , Torp-Pedersen C , McMurray JJ ; Dronedarone Study Group. Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med 2008; 358:2678–87.

Jondeau G , Neuder Y , Eicher JC ; B-CONVINCED Investigators. B-CONVINCED: Beta-blocker CONtinuation Vs Interruption in patients with Congestive heart failure hospitalizED for a decompensation episode. Eur Heart J 2009; 30:2186–92.

Pantos C , Mourouzis I , Cokkinos DV . New insights into the role of thyroid hormone in cardiac remodeling: time to reconsider? Heart Fail Rev 2011; 16:79–96.

Iervasi G , Pingitore A , Landi P . Low-T3. syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation 2003; 107:708–13.

Pantos C , Dritsas A , Mourouzis I . Thyroid hormone is a critical determinant of myocardial performance in patients with heart failure: potential therapeutic implications. Eur J Endocrinol 2007; 157:515–20.

Galli E , Pingitore A , Iervasi G . The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence. Heart Fail Rev 2010; 15:155–69.

Goldman S , McCarren M , Morkin E . DITPA (3,5-Diiodothyropropionic Acid), a thyroid hormone analog to treat heart failure: phase II trial Veterans Affairs cooperative study. Circulation 2009; 119:3093–100.

Pingitore A , Iervasi G , Gerdes MA . Letter by Pingitore et al. regarding article, “DITPA (3,5-diiodothyropropionic acid), a thyroid hormone analog to treat heart failure: phase II trial Veterans Affairs cooperative study.” Circulation 2010; 121:e240.

Pantos C , Mourouzis I , Xinaris C , Papadopoulou-Daifoti Z , Cokkinos D . Thyroid hormone and “cardiac metamorphosis”: potential therapeutic implications. Pharmacol Ther 2008; 118:277–94.

Pantos C , Mourouzis I , Galanopoulos G . Thyroid hormone receptor alpha1 downregulation in postischemic heart failure progression: the potential role of tissue hypothyroidism. Horm Metab Res 2010; 42:718–24.

Han TS , Williams GR , Vanderpump MP . Benzofuran derivatives and the thyroid. Clin Endocrinol (Oxf) 2009; 70:2–13.

Van Beeren HC , Jong WM , Kaptein E , Visser TJ , Bakker O , Wiersinga WM . Dronerarone acts as a selective inhibitor of 3,5,3′-triiodothyronine binding to thyroid hormone receptor-alpha1: in vitro and in vivo evidence. Endocrinology 2003; 144:552–8.

Pantos C , Mourouzis I , Malliopoulou V . Dronedarone administration prevents body weight gain and increases tolerance of the heart to ischemic stress: a possible involvement of thyroid hormone receptor alpha1. Thyroid 2005; 15:16–23.

Agelaki MG , Pantos C , Korantzopoulos P . Comparative antiarrhythmic efficacy of amiodarone and dronedarone during acute myocardial infarction in rats. Eur J Pharmacol 2007; 564:150–7.

Prescribing information. Dronedarone (Multaq). Bridgewater, NJ: Sanofi-Aventis US LLC, July 2009.